Skip to main content
Skip to Investors Navigation
About
Company
Management Team
Corporate Governance
Technology
Pb-based α-Particle Therapy
Precision Radiopharmaceuticals
Pb-Specific Chelator (PSC)
Theranostics Platform
Manufacturing/Logistics
Therapeutic Areas
Neuroendocrine Tumors
Melanoma
Solid Tumors
Pipeline
Program Overview
VMT-α-NET
VMT01/02
PSV359
Pre-Targeting Platform
Expanded Access
Newsroom
News
Press Releases
Publications
Investor Center
Overview
Events
SEC Filings
Stock Data
Corporate Governance
Contact Info
Alerts
About
Management Team
Meet our talented team members
About Perspective Therapeutics